|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.026 AUD | -3.70% |
|
+13.04% | +8.33% |
| 05-13 | AdAlta Signs Master Services Agreement with Cell Therapies; Shares Up 4% | MT |
| 04-29 | AdAlta Secures Up to AU$3.7 Million for MOU, i-body Programs | MT |
AdAlta Limited reported earnings results for the half year ended December 31, 2021. For the half year, the company reported sales was AUD 0.727268 million compared to AUD 0.806501 million a year ago. Net loss was AUD 3.66 million compared to AUD 4.51 million a year ago.
Basic loss per share from continuing operations was AUD 0.0148 compared to AUD 0.0206 a year ago. Diluted loss per share from continuing operations was AUD 0.0148 compared to AUD 0.0206 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.33% | 9.56M | |
| +11.16% | 115B | |
| +12.85% | 106B | |
| -4.13% | 24.69B | |
| -2.33% | 21.97B | |
| -6.03% | 19.27B | |
| -11.79% | 17.56B | |
| -40.50% | 17.32B | |
| +7.58% | 14.03B | |
| +32.89% | 12.13B |
ADALTA LIMITED 
